(E)-7-Nitro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzo[c][1,2,5]oxadiazol-4-amine

Catalog No. :
ACZXLA565
CAS No. :
2304482-80-0
Molecular Formula :
C15H19BN4O5
Molecular Weight :
346.15

IUPAC Name:(E)-7-nitro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzo[c][1,2,5]oxadiazol-4-amine

(E)-7-Nitro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzo[c][1,2,5]oxadiazol-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-7-Nitro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzo[c][1,2,5]oxadiazol-4-amine
IUPAC Name(E)-7-nitro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzo[c][1,2,5]oxadiazol-4-amine
Molecular FormulaC15H19BN4O5
Molecular Weight346.15
SMILESCC1(C)C(C)(C)OB(/C=C/CNC2=CC=C([N+]([O-])=O)C3=NON=C32)O1
InChI KeyPIEXUSWRAONSNT-VMPITWQZSA-N
CAS No.2304482-80-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZXLA565 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJSFV723 route compound structure diagram
    ACJSFV72310199-89-0 In Stock
  4. Then
  5. ACZXLA565 route product structure diagram
    ACZXLA5652304482-80-0
Inquiry

2. ACZXLA565 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKRZX346 route compound structure diagram
    ACKRZX34610199-91-4 In Stock
  4. Then
  5. ACZXLA565 route product structure diagram
    ACZXLA5652304482-80-0
Inquiry

Comments (0)